Neratinib - HKI 272

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 1526

CAS [698387-09-6]

MF C30H29ClN6O3
MW 557.04

  • Purity: 98%
  • Soluble in 0.1N HCl(aq) and DMSO

Neratinib

Description

An irreversible tyrosine kinase inhibitor with activity against HER2 and EGFR kinases; a therapeutic agent under investigation for the treatment breast cancer and other solid tumors.

KEYWORDS: Neratinib | supplier | EGFR/HER2 inhibitor | HKI 272 | HKI272 | CAS [698387-09-6] | EGFR | ErbB2-HER2 | RTK | breast cancer | solid tumors | NSCLC | growth factor receptor

Order
Size Unit Price Stock
5 mg €90.00 In Stock
25 mg €290.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €140.00 In Stock
2 x 25 mg €460.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...